Form 4: NHI CEO Mendelsohn Reports Stock Grant, Option Activity

NATIONAL HEALTH INVESTORS INC CEO D. Eric Mendelsohn reported the acquisition of 14,409 restricted shares and disposition of 597 shares for tax purposes, alongside new stock option grants.

Summary

• D. Eric Mendelsohn, CEO and President of National Health Investors Inc. (NHI), reported changes in his beneficial ownership.
• Acquired 14,409 shares of common stock as a restricted stock grant on March 3, 2026, with a grant price of $0.
• Disposed of 597 shares of common stock on March 3, 2026, at a price of $86.75 per share, to satisfy tax withholding obligations in connection with the vesting of restricted stock.
• Following these transactions, Mendelsohn beneficially owns 132,210 shares of common stock directly.
• Received two grants of stock options, each for 25,000 shares, with an exercise price of $73.34 per share.
• The first option grant becomes exercisable on March 3, 2026, and expires on March 3, 2030.
• The second option grant becomes exercisable on March 3, 2027, and expires on March 3, 2030.
• The restricted stock grant vests in three equal annual installments starting March 3, 2027, contingent on continued service through each vesting date.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting ongoing executive compensation and alignment of management incentives with shareholder value, without indicating any immediate operational changes or financial distress.

Positives

• CEO D. Eric Mendelsohn received a grant of 14,409 restricted shares, aligning his interests with long-term shareholder value.
• New stock option grants for a total of 50,000 shares (two grants of 25,000 shares each) provide further incentive for management performance.

Negatives

• Disposition of 597 shares to cover tax obligations, though a common practice, results in a slight reduction of direct ownership.

Risks

• The vesting of restricted stock and exercisability of options are subject to the reporting person's continued service, posing a risk if employment terminates before vesting/exercisability dates.

Future Outlook

The restricted stock grant is structured to vest in three equal annual installments beginning March 3, 2027, subject to D. Eric Mendelsohn's continued service. The stock options have exercisable dates of March 3, 2026, and March 3, 2027, with an expiration date of March 3, 2030.

Management Comments

• Not applicable for this type of filing.

Industry Context

StockSavvy.ai notes that executive compensation packages often include restricted stock and stock options to align management incentives with long-term shareholder interests, a common practice in the healthcare REIT sector to retain key talent and drive performance.

Comparison to Industry Standards

• The grant of restricted stock and stock options to a CEO is a standard component of executive compensation packages across various industries, including healthcare REITs, designed to incentivize long-term performance and retention.
• The vesting schedule for restricted stock (three equal annual installments) and the multi-year exercisable/expiration dates for options are typical structures aimed at fostering sustained commitment.
• The disposition of shares for tax withholding upon vesting is a routine and expected event for equity compensation.

Stakeholder Impact

• Shareholders: Increased alignment of CEO's interests with long-term shareholder value through equity grants.
• Employees: No direct impact on general employees, but reinforces executive compensation structure.

Next Steps

• First installment of restricted stock vests on March 3, 2027.
• Second stock option grant becomes exercisable on March 3, 2027.
• Remaining restricted stock installments will vest annually thereafter, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation, including restricted stock and option grants, and a tax-related share disposition. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transactions are expected and reflect standard incentive alignment.

Keywords

National Health Investors, NHI, D. Eric Mendelsohn, Form 4, Insider Trading, Restricted Stock, Stock Options, Executive Compensation, Beneficial Ownership